Tianjin Huanhu Hospital
Tianjin, 300350, China
NCT Number: NCT05909982
Ischemic post-conditioning is a neuroprotective strategy attenuating reperfusion injury in animal stroke models. The investigators have conducted a 3 + 3 dose-escalation trial to demonstrate the safety and tolerability of ischemic post-conditioning incrementally for a longer duration of up to 5 min × 4 cycles in stroke patients undergoing mechanical thrombectomy. This study aims to assess the infarct volume after ischemic post-conditioning in patients with acute ischemic stroke who are treated with mechanical thrombectomy.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 1 / Phase 2
Tianjin, 300350, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ischemic post-conditioning will be applied after successful recanalization of the culprit artery by thrombectomy. Ischemic post-conditioning consists of briefly repeated four cycles × 2 minutes of occlusion and reperfusion (equal duration) of the initially occluded artery using a balloon.
Time frame: 72 hours after procedure
Infarct volume at 72 hours after procedure
Time frame: Baseline and 72 hours after procedure
Difference of infarct volume between baseline and 72 hours after procedure
Time frame: 90 days after procedure
The modified Rankin Scale (mRS) score of 0-2 at 90 days after procedure; the mRS is an ordinal disability score of 7 categories (0=no symptoms to 5=severe disability, and 6=death)
Time frame: 90 days after procedure
The mRS score of 0-3 at 90 days after procedure; the mRS is an ordinal disability score of 7 categories (0=no symptoms to 5=severe disability, and 6=death)
Time frame: 90 days after procedure
The distribution of the mRS score at 90 days after procedure; the mRS is an ordinal disability score of 7 categories (0=no symptoms to 5=severe disability, and 6=death)
Time frame: 24 hours after procedure
NIHSS score at 24 hours after procedure; the NIHSS ranges from 0 to 42, with higher scores indicating more severe neurologic deficits
Time frame: 24 hours after procedure
NIHSS 0-2 or ≥8 lower than baseline NIHSS score at 24 hours after procedure; the NIHSS ranges from 0 to 42, with higher scores indicating more severe neurologic deficits
Time frame: 7 days after procedure/discharge
NIHSS score at 7 days after procedure/discharge; the NIHSS ranges from 0 to 42, with higher scores indicating more severe neurologic deficits
Time frame: 24 hours after procedure
Recanalization rate at 24 hours after procedure (mTICI ≥2b)
Time frame: Within 24 hours after procedure
Hemodynamic assessment within 24 hours after procedure
Time frame: 90 days after procedure
90-day mortality
Time frame: Within 24 hours after procedure
The proportion of symptomatic intracranial hemorrhage within 24 hours after procedure
Time frame: Within 24 hours after procedure
The proportion of intracranial hemorrhage within 24 hours after procedure
Time frame: Within 24 hours after procedure
The proportion of malignant brain edema within 24 hours after procedure
Time frame: During the procedure
Vascular perforation/rupture, vessel dissection, severe vasospasm, rupture of the balloon used for post-conditioning
Capital Medical University
Other
Effect of Ischemic Post-conditioning on Infarct Volume in Patients With Acute Ischemic Stroke After Mechanical Thrombectomy
Acronym: PROTECT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07422636
Acute Ischemic Stroke, Animal Diseases
Florence, Italy
View Trial DetailsNCT07526649
Acute Ischemic Stroke, Brain Diseases
Grafton, Auckland, New Zealand
View Trial DetailsNCT05145283
Acute Ischemic Stroke, Acute Kidney Injury
Basel, Switzerland
View Trial DetailsNCT07495722
Acute Ischemic Stroke, Blood Coagulation Disorders
View Trial Details